Iron deficiency and anemia predict mortality in patients with tuberculosis

Journal of Nutrition

Volumn 142, Issue 2, 2012, Pages 350-357

  Isanaka, Sheila ^a   Mugusi, Ferdinand ^b   Urassa, Willy ^b   Willett, Walter C ^a,c   Bosch, Ronald J ^a   Villamor, Eduardo ^a,d   Spiegelman, Donna ^a   Duggan, Christopher ^a,e   Fawzi, Wafaie W ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IRON DEFICIENCY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MORTALITY; PREDICTION; RECURRENT DISEASE; RISK ASSESSMENT; TREATMENT FAILURE;

ADULT; ANEMIA, IRON-DEFICIENCY; DIETARY SUPPLEMENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; TANZANIA; TUBERCULOSIS; YOUNG ADULT;

EID: 84858269914     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.144287     Document Type: Article

References (50)

1. WHO. Global tuberculosis control: WHO report 2010. Geneva: WHO; 2010.
2. WHO. Report of the Scientific Working Group meeting on Tuberculosis, October 3-6, 2005. Geneva: WHO; 2006.
3. WHO and the CDC. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. Geneva: WHO; 2008.
4. Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19: 29-33.
5. Moyle G. Anaemia in persons with HIV infection: prognostic marker and contributor to morbidity. AIDS Rev. 2002;4:13-20.
6. O'Brien ME, Kupka R, Msamanga GI, Saathoff E, Hunter DJ, Fawzi WW. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr. 2005;40:219-25.
7. Karyadi E, Schultink W, Nelwan RH, Gross R, Amin Z, Dolmans WM, van der Meer JW, Hautvast JG, West CE. Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia. J Nutr. 2000;130:2953-8.
8. Lee SW, Kang YA, Yoon YS, Um SW, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ. The prevalence and evolution of anemia associated with tuberculosis. J Korean Med Sci. 2006;21:1028-32.
9. Sahiratmadja E, Wieringa FT, van Crevel R, de Visser AW, Adnan I, Alisjahbana B, Slagboom E, Marzuki S, Ottenhoff TH, van de Vosse E, et al. Iron deficiency and NRAMP1 polymorphisms (INT4, D543N and 39UTR) do not contribute to severity of anaemia in tuberculosis in the Indonesian population. Br J Nutr. 2007;98:684-90.
10. Shah S, Whalen C, Kotler DP, Mayanja H, Namale A, Melikian G, Mugerwa R, Semba RD. Severity of human immunodeficiency virus infection is associated with decreased phase angle, fat mass and body cell mass in adults with pulmonary tuberculosis infection in Uganda. J Nutr. 2001;131:2843-7.
11. van Lettow M, West CE, van der Meer JW, Wieringa FT, Semba RD. Low plasma selenium concentrations, high plasma human immunodeficiency virus load and high interleukin-6 concentrations are risk factors associated with anemia in adults presenting with pulmonary tuberculosis in Zomba district, Malawi. Eur J Clin Nutr. 2005;59:526-32.
12. Kourbatova EV, Borodulin BE, Borodulina EA, del Rio C, Blumberg HM, Leonard MK Jr. Risk factors for mortality among adult patients with newly diagnosed tuberculosis in Samara, Russia. Int J Tuberc Lung Dis. 2006;10:1224-30.
13. Mehta JB, Fields CL, Byrd RP Jr, Roy TM. Nutritional status and mortality in respiratory failure caused by tuberculosis. Tenn Med. 1996;89:369-71.
14. Sacks LV, Pendle S. Factors related to in-hospital deaths in patients with tuberculosis. Arch Intern Med. 1998;158:1916-22.
15. Dallman PR. Iron deficiency and the immune response. Am J Clin Nutr. 1987;46:329-34.
16. Oppenheimer SJ. Iron and its relation to immunity and infectious disease. J Nutr. 2001;131:S616-33; discussion S33-5.
17. Villamor E, Mugusi F, Urassa W, Bosch RJ, Saathoff E, Matsumoto K, Meydani SN, Fawzi WW. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. J Infect Dis. 2008;197:1499-505.
18. Urassa W, Mugusi F, Villamor E, Msamanga G, Moshiro C, Bosch R, Saathoff E, Fawzi W. Primary antimicrobial resistance among Mycobacterium tuberculosis isolates from HIV seropositive and HIV seronegative patients in Dar es Salaam Tanzania. BMC Res Notes. 2008;1:58.
19. WHO. Interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec. 1990;65:221-4.
20. Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber DA, Means RT, editors. Wintrobe's clinical hematology. 12th ed. Philadelphia: Lippincott Williams & Wilkins; 2009.
21. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162:199-200.
22. D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med. 1990;9:1501-15.
23. Cole SR, Hernan MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168:656-64.
24. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550-60.
25. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551-61.
26. Govindarajulu US, Spiegelman D, Thurston SW, Ganguli B, Eisen EA. Comparing smoothing techniques in Cox models for exposure-response relationships. Stat Med. 2007;26:3735-52.
27. Friis H, Range N, Braendgaard Kristensen C, Kaestel P, Changalucha J, Malenganisho W, Krarup H, Magnussen P, Bengaard Andersen A. Acute- phase response and iron status markers among pulmonary tuberculosis patients: a cross-sectional study in Mwanza, Tanzania. Br J Nutr. 2009;102:310-7.
28. Morris CD, Bird AR, Nell H. The haematological and biochemical changes in severe pulmonary tuberculosis. Q J Med. 1989;73:1151-9.
29. Das BS, Devi U, Mohan Rao C, Srivastava VK, Rath PK, Das BS. Effect of iron supplementation on mild to moderate anaemia in pulmonary tuberculosis. Br J Nutr. 2003;90:541-50.
30. Ekiz C, Agaoglu L, Karakas Z, Gurel N, Yalcin I. The effect of iron deficiency anemia on the function of the immune system. Hematol J. 2005;5:579-83.
31. Sipahi T, Akar N, Egin Y, Cin S. Serum interleukin-2 and interleukin-6 levels in iron deficiency anemia. Pediatr Hematol Oncol. 1998;15:69-73.
32. Clerici M, Shearer GMA. TH1 → TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993;14:107-11.
33. Cronjé L, Edmondson N, Eisenach KD, Bornman L. Iron and iron chelating agents modulate Mycobacterium tuberculosis growth and monocyte-macrophage viability and effector functions. FEMS Immunol Med Microbiol. 2005;45:103-12.
34. Raghu B, Sarma GR, Venkatesan P. Effect of iron on the growth and siderophore production of mycobacteria. Biochem Mol Biol Int. 1993;31:341-8.
35. Kochan I. The role of iron in bacterial infections, with special consideration of host-tubercle bacillus interaction. Curr Top Microbiol Immunol. 1973;60:1-30.
36. Serafin-López J, Chacon-Salinas R, Munoz-Cruz S, Enciso-Moreno JA, Estrada-Parra SA, Estrada-Garcia I. The effect of iron on the expression of cytokines in macrophages infected with Mycobacterium tuberculosis. Scand J Immunol. 2004;60:329-37.
37. Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G. Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin. Kidney Int. 2003;64:572-8.
38. Weiss G. Iron and immunity: a double-edged sword. Eur J Clin Invest. 2002;32 Suppl 1:70-8.
39. Schaible UE, Collins HL, Priem F, Kaufmann SH. Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J Exp Med. 2002;196:1507-13.
40. Weiss G, Werner-Felmayer G, Werner ER, Grunewald K, Wachter H, Hentze MW. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med. 1994;180:969-76.
41. Gangaidzo IT, Moyo VM, Mvundura E, Aggrey G, Murphree NL, Khumalo H, Saungweme T, Kasvosve I, Gomo ZA, Rouault T, et al. Association of pulmonary tuberculosis with increased dietary iron. J Infect Dis. 2001;184:936-9.
42. Gordeuk VR, McLaren CE, MacPhail AP, Deichsel G, Bothwell TH. Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited. Blood. 1996;87: 3470-6.
43. Boelaert JR, Weinberg GA, Weinberg ED. Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. Infect Agents Dis. 1996;5:36-46.
44. Savarino A, Pescarmona GP, Boelaert JR. Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences? Cell Biochem Funct. 1999;17:279-87.
45. de Monyé C, Karcher DS, Boelaert JR, Gordeuk VR. Bone marrow macrophage iron grade and survival of HIV-seropositive patients. AIDS. 1999;13:375-80.
46. Gordeuk VR, Onojobi G, Schneider MF, Dawkins FW, Delapenha R, Voloshin Y, von Wyl V, Bacon M, Minkoff H, Levine A, et al. The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection. Haematologica. 2006;91:739-43.
47. McDermid JM, Jaye A, Schim van der Loeff MF, Todd J, Bates C, Austin S, Jeffries D, Awasana AA, Whittlex AA, Prentice A. Elevated iron status strongly predicts mortality in West African adults with HIV infection. J Acquir Immune Defic Syndr. 2007;46:498-507.
48. Lounis N, Truffot-Pernot C, Grosset J, Gordeuk VR, Boelaert JR. Iron and Mycobacterium tuberculosis infection. J Clin Virol. 2001;20:123-6.
49. WHO and the CDC. Assessing the iron status of populations. Geneva: WHO; 2004.
50. Steinberg MH, Dreiling BJ. Microcytosis. Its significance and evaluation. JAMA. 1983;249:85-7.